Latest NewsSep 14, 2024HiFiBiO Therapeutics to Present Phase 1 Clinical Trial Data for Two Novel Immuno-Oncology Antibodies at the 2024 Annual Congress of the European Society for Medical OncologyAll Filter By: Year2024202320222021202020192018201720162015Oct 2, 2018Research Collaboration to Develop Technology for the Treatment of CancerJul 30, 2018HiFiBiO Therapeutics Signs Multi-Target Antibody Discovery Agreement with TakedaMay 16, 2018HiFiBiO Therapeutics Secures $37.5 Million Series B Financing to Accelerate Pipeline of Novel Antibody Drugs to Treat Cancer and Autoimmune DisordersOct 12, 2017HiFiBiO and collaborators publish single-cell microfluidics work in Nature BiotechnologyOct 9, 2017Shared Insights About Guiding Principles of Open Collaboration in Drug Discovery Today From HiFiBiO CEO Liang SchweizerSep 11, 2017Single-Cell Deep Phenotyping of lgG-Secreting Cells for High-Resolution Immune Monitoring< 1 … 10 11 12 13 14 >